Hyperandrogenism and Insulin Resistance, Not Changes in Body Weight, Mediate the Development of Endothelial Dysfunction in a Female Rat Model of Polycystic Ovary Syndrome (PCOS)

被引:38
作者
Hurliman, Amanda [1 ,5 ]
Brown, Jennifer Keller [1 ,4 ]
Maille, Nicole [2 ]
Mandala, Maurizio [2 ,3 ]
Casson, Peter [1 ,4 ]
Osol, George [2 ]
机构
[1] Univ Vermont, Div Reprod Endocrinol & Infertil, Burlington, VT 05405 USA
[2] Univ Vermont, Dept Obstet Gynecol & Reprod Sci, Burlington, VT 05405 USA
[3] Univ Calabria, Dept Cell Biol, I-87030 Cosenza, Italy
[4] Northeastern Reprod Med, Colchester, VT 05446 USA
[5] Oregon Reprod Med, Portland, OR 97210 USA
关键词
YOUNG-WOMEN; ADIPOSE-TISSUE; NITRIC-OXIDE; METFORMIN; SENSITIVITY; ACTIVATION; ENDOCRINE; NONOBESE; CORONARY; THERAPY;
D O I
10.1210/en.2015-1159
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
This study was designed to differentiate the contributions of hyperandrogenism, insulin resistance (IR), and body weight to the development of endothelial dysfunction in polycystic ovary syndrome and determine the effectiveness of insulin sensitization and antiandrogenic therapy after the establishment of vascular and metabolic dysfunction using a rat model of polycystic ovary syndrome. We hypothesized that the observed endothelial dysfunction was a direct steroidal effect, as opposed to changes in insulin sensitivity or body weight. Prepubertal female rats were randomized to the implantation of a pellet containing DHT or sham procedure. In phase 1, DHT-exposed animals were randomized to pair feeding to prevent weight gain or metformin, an insulin-sensitizing agent, from 5 to 14 weeks. In phase 2, DHT-exposed animals were randomized to treatment with metformin or flutamide, a nonsteroidal androgen receptor blocker from 12 to 16 weeks. Endothelial function was assessed by the vasodilatory response of preconstricted arteries to acetylcholine. Serum steroid levels were analyzed in phase 1 animals. Fasting blood glucose and plasma insulin were analyzed and homeostasis model assessment index calculated in all animals. Our data confirm the presence of endothelial dysfunction as well as increased body weight, hypertension, hyperinsulinemia, and greater IR among DHT-treated animals. Even when normal weight was maintained through pair feeding, endothelial dysfunction, hyperinsulinemia, and IR still developed. Furthermore, despite weight gain, treatment with metformin and flutamide improved insulin sensitivity and blood pressure and restored normal endothelial function. Therefore, the observed endothelial dysfunction is most likely a direct result of hyperandrogenism-induced reductions in insulin sensitivity, as opposed to weight gain.
引用
收藏
页码:4071 / 4080
页数:10
相关论文
共 49 条
[1]   CLOSE RELATION OF ENDOTHELIAL FUNCTION IN THE HUMAN CORONARY AND PERIPHERAL CIRCULATIONS [J].
ANDERSON, TJ ;
UEHATA, A ;
GERHARD, MD ;
MEREDITH, IT ;
KNAB, S ;
DELAGRANGE, D ;
LIEBERMAN, EH ;
GANZ, P ;
CREAGER, MA ;
YEUNG, AC ;
SELWYN, AP .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1995, 26 (05) :1235-1241
[2]   Androgen metabolism in adipose tissue: Recent advances [J].
Blouin, Karine ;
Veilleux, Alain ;
Luu-The, Van ;
Tchernof, Andre .
MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2009, 301 (1-2) :97-103
[3]   Peroxisome proliferator-activated receptors as transcriptional nodal points and therapeutic targets [J].
Brown, Jonathan D. ;
Plutzky, Jorge .
CIRCULATION, 2007, 115 (04) :518-533
[4]   Validation of simple indexes to assess insulin sensitivity during pregnancy in Wistar and Sprague-Dawley rats [J].
Cacho, J. ;
Sevillano, J. ;
de Castro, J. ;
Herrera, E. ;
Ramos, M. P. .
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2008, 295 (05) :E1269-E1276
[5]   Metformin influence on hormone levels at birth, in PCOS mothers and their newborns [J].
Carlsen, S. M. ;
Vanky, E. .
HUMAN REPRODUCTION, 2010, 25 (03) :786-790
[6]   The polycystic ovary syndrome: a position statement from the European Society of Endocrinology [J].
Conway, Gerard ;
Dewailly, Didier ;
Diamanti-Kandarakis, Evanthia ;
Escobar-Morreale, Hector F. ;
Franks, Stephen ;
Gambineri, Alessandra ;
Kelestimur, Fahrettin ;
Macut, Djuro ;
Micic, Dragan ;
Pasquali, Renato ;
Pfeifer, Marija ;
Pignatelli, Duarte ;
Pugeat, Michel ;
Yildiz, Bulent O. .
EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2014, 171 (04) :P1-P29
[7]   Activation of the AMP-activated kinase by antidiabetes drug metformin stimulates nitric oxide synthesis in vivo by promoting the association of heat shock protein 90 and endothelial nitric oxide synthase [J].
Davis, BJ ;
Xie, ZL ;
Viollet, B ;
Zou, MH .
DIABETES, 2006, 55 (02) :496-505
[8]   Peroxisome proliferator-activated receptor activators inhibit thrombin-induced endothelin-1 production in human vascular endothelial cells by inhibiting the activator protein-1 signaling pathway [J].
Delerive, P ;
Martin-Nizard, F ;
Chinetti, G ;
Trottein, F ;
Fruchart, JC ;
Najib, J ;
Duriez, P ;
Staels, B .
CIRCULATION RESEARCH, 1999, 85 (05) :394-402
[9]   Metformin prevents high-glucose-induced endothelial cell death through a mitochondrial permeability transition-dependent process [J].
Detaille, D ;
Guigas, B ;
Chauvin, C ;
Batandier, C ;
Fontaine, E ;
Wiernsperger, N ;
Leverve, X .
DIABETES, 2005, 54 (07) :2179-2187
[10]   Metformin administration improves endothelial function in women with polycystic ovary syndrome [J].
Diamanti-Kandarakis, E ;
Alexandraki, K ;
Protogerou, A ;
Piperi, C ;
Papamichael, C ;
Aessopos, A ;
Lekakis, J ;
Mavrikakis, M .
EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2005, 152 (05) :749-756